Skip to main content

Want a detailed portfolio tracker?

Dyne Therapeutics (DYN) P/E (2020 - 2026)

Dyne Therapeutics (DYN) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Dyne Therapeutics (DYN) P/E is -7.60. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Dyne Therapeutics (DYN)

YearP/EChange
2026-7.60+32.85%
2025-5.72-21.53%
2024-7.29+91.81%
2023-3.80+14.75%
2022-3.31-19.15%
2021-4.09-81.58%
2020-22.22N/A

Comparison Dyne Therapeutics (DYN) P/E with competitors

Dyne Therapeutics (DYN) P/E is -7.60.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-100.98%
FGENFibroGen Inc0.24-103.16%
CHRSCoherus Biosciences Inc0.85-111.17%
FBIOFortress Biotech Inc0.95-112.49%
ORMPOramed Pharmaceuticals Inc1.50-119.79%
AGENAgenus Inc3.01-139.62%
INVAInnoviva Inc3.15-141.52%
VXRTVaxart Inc3.55-146.73%
CRMDCorMedix Inc3.63-147.77%
CVACCureVac N.V.4.45-158.53%
GLPGGalapagos NV4.86-163.97%
SRPTSarepta Therapeutics Inc4.88-164.27%
ABEOAbeona Therapeutics Inc5.39-170.93%
ABUSArbutus Biopharma Corp5.60-173.67%
ZVRAZevra Therapeutics Inc5.89-177.51%
SPROSpero Therapeutics Inc6.23-182.00%
CGENCompugen Ltd6.31-183.12%
RIGLRigel Pharmaceuticals6.87-190.47%
SLXNSilexion Therapeutics Corp7.30-196.05%
OMEROmeros Corporation9.26-221.89%
AUPHAurinia Pharmaceuticals Inc9.58-226.19%
PLXProtalix BioTherapeutics Inc10.89-243.38%
ACADAcadia Pharmaceuticals Inc11.73-254.41%
TBPHTheravance Biopharma Inc12.26-261.43%
ADMAAdma Biologics Inc12.42-263.49%
HRMYHarmony Biosciences Holdings Inc13.82-281.95%
SABSSAB Biotherapeutics Inc14.14-286.11%
NAGENiagen Bioscience Inc14.82-295.08%
INCYIncyte Corp15.82-308.31%
REGNRegeneron Pharmaceuticals Inc15.86-308.76%
PBYIPuma Biotechnology Inc17.32-327.96%
CPRXCatalyst Pharmaceuticals Inc17.44-329.59%
EXELExelixis Inc17.54-330.89%
TGTXTG Therapeutics Inc18.97-349.69%
MDXGMimedx Group Inc20.55-370.58%
XOMAXOMA Royalty Corp22.87-401.16%
ARGXArgen X SE24.30-419.90%
CTMXCytomX Therapeutics Inc24.82-426.78%
XOMAOXOMA Royalty Corp25.34-433.68%
HALOHalozyme Therapeutics Inc25.62-437.35%
XOMAPXOMA Royalty Corp25.67-437.96%
VRTXVertex Pharmaceuticals Inc27.99-468.57%
RPRXRoyalty Pharma plc - Class A28.69-477.69%
SLNOSoleno Therapeutics Inc29.02-482.00%
ASNDAscendis Pharma A/S30.09-496.09%
LGNDLigand Pharmaceuticals Inc - Class B37.91-599.13%
APLSApellis Pharmaceuticals Inc39.02-613.73%
BMRNBiomarin Pharmaceutical Inc42.21-655.74%
KRYSKrystal Biotech Inc45.34-696.97%
ONCBeiGene Ltd69.54-1015.54%
PHARPharming Group N.V.75.03-1087.75%
TECHBio-Techne Corp101.96-1442.34%
VCELVericel Corp109.92-1547.17%
ALNYAlnylam Pharmaceuticals Inc117.96-1653.07%
GMABGenmab140.29-1947.00%
TLXTelix Pharmaceuticals Ltd162.15-2234.83%
CORTCorcept Therapeutics Inc212.86-2902.38%